In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best stocks to buy for financial stability. Investing in stocks is one of the most effective ...

Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion or more. Leverage the power of TipRanks' Smart Score, a data-driven ...

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Shareholder Yield Investor model based on the published ...

Guggenheim analyst Vamil Divan maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target of ...

Pharmaceutical giants Johnson & Johnson and Sanofi have stopped a late-stage clinical trial for their experimental E.coli vaccine after results failed to demonstrate sufficient efficacy.

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best medical device stocks to buy right now. According to a report by Mordor Intelligence ...

J&J is exploring the sale of Cerenovus, a stroke care business, in a deal potentially worth $1 billion to $1.5 billion. The company spent over $30 billion on medtech acquisitions in the past three ...

Johnson & Johnson (NYSE: JNJ) is one of the world's largest and most prominent healthcare leaders. If investing in a company came down to size, the stock would be a no-brainer buy. However ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other stocks. Wall Street ended the first trading day of the week on a mixed note, with the ...

Play the USA TODAY Daily Crossword Puzzle. INSTANT TAKE:Detroit Lions' window is still open — even though they lost Ben Johnson Johnson was considered the top coaching candidate on the market ...